Fulgent Genetics, Inc.

NASDAQ:FLGT

19.43 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 71.02864.48570.50584.68767.85366.16867.704105.655125.341320.268251.671227.868153.616359.429294.978101.71617.2657.7538.38710.3478.4245.375.6795.6255.44.6534.2814.5034.645.3065.8545.0113.9713.442.9012.9052.1811.588
Cost of Revenue 46.52744.37147.23444.84347.28147.35754.71759.5660.06577.72562.13443.46635.85874.07551.77226.2617.7174.0573.6343.8853.622.9682.7642.6122.5442.7722.5452.2681.8791.8591.8632.0991.4111.3042.7260.9180.7720.653
Gross Profit 24.50120.11423.27139.84420.57218.81112.98746.09565.276242.543189.537184.402117.758285.354243.20675.4559.5483.6964.7536.4624.8042.4022.9153.0132.8561.8811.7362.2352.7613.4473.9912.9122.562.1360.1751.9871.4090.935
Gross Profit Ratio 0.3450.3120.330.470.3030.2840.1920.4360.5210.7570.7530.8090.7670.7940.8240.7420.5530.4770.5670.6250.570.4470.5130.5360.5290.4040.4060.4960.5950.650.6820.5810.6450.6210.060.6840.6460.589
Reseach & Development Expenses 13.48611.43411.95210.0149.6929.7828.5097.5076.9055.9897.4646.0215.3125.4224.5763.1771.8491.9781.7951.7441.5741.4241.4261.4381.2121.4581.3241.1280.920.8510.8181.5050.6560.5613.6490.3110.2530.217
General & Administrative Expenses 21.32621.48931.70617.49817.99321.80228.79326.26630.2425.77522.10212.2998.3298.0027.643.7411.7992.0351.7321.5221.6311.5291.3781.3061.3661.4871.3021.2051.141.4861.1161.1350.4571.8891.9570.2160.1670.079
Selling & Marketing Expenses 8.5958.98910.510.16110.72310.08310.2539.85910.8667.948.26.0125.2195.0085.0815.0143.261.5971.6351.6871.3041.2721.1271.1151.2791.131.0981.3830.8510.8910.7980.8830.4770.3011.9130.280.2430.234
SG&A 29.92130.47842.20627.65928.71631.88539.04636.12541.10633.71530.30218.31113.54813.0112.7218.7555.0593.6323.3673.2092.9352.8012.5052.4212.6452.6172.42.5881.9912.3771.9142.0180.9342.193.870.4960.410.313
Other Expenses 1.990-5.8871.9571.9621.9682.012.0061.5750.9060.9110.79700000000000000000000000000
Operating Expenses 43.40741.91254.15839.6340.3743.63549.56545.63849.58640.6138.67725.12918.8618.43217.29711.9326.9085.615.1624.9534.5094.2253.9313.8593.8574.0753.7243.7162.9113.2282.7323.5231.592.7517.5190.8070.6630.53
Operating Income -18.906-21.798-30.8870.214-19.798-24.824-36.5780.56218.586201.933150.86159.27398.898266.922225.90963.5232.64-1.914-0.4091.5090.295-1.823-1.016-0.846-1.001-2.194-1.988-1.481-0.150.2191.259-0.6110.97-0.615-7.3441.180.7460.405
Operating Income Ratio -0.266-0.338-0.4380.003-0.292-0.375-0.540.0050.1480.6310.5990.6990.6440.7430.7660.6250.153-0.247-0.0490.1460.035-0.339-0.179-0.15-0.185-0.472-0.464-0.329-0.0320.0410.215-0.1220.244-0.179-2.5320.4060.3420.255
Total Other Income Expenses Net 7.6927.625-114.3096.6465.0983.7753.1161.195-4.8340.045-0.6970.4960.6040.2820.5890.4210.2750.2410.2490.1890.1920.2070.0980.1430.0980.0950.0970.1450.120.1190.0580.005-5.4620.0130.007000.02
Income Before Tax -11.214-14.173-145.1966.86-14.7-21.049-33.4621.75713.752201.978150.825159.76999.502267.204226.49863.9442.915-1.673-0.161.6980.487-1.616-0.918-0.703-0.903-2.099-1.891-1.336-0.030.3381.316-0.606-4.492-0.602-7.3371.180.7460.425
Income Before Tax Ratio -0.158-0.22-2.0590.081-0.217-0.318-0.4940.0170.110.6310.5990.7010.6480.7430.7680.6290.169-0.216-0.0190.1640.058-0.301-0.162-0.125-0.167-0.451-0.442-0.297-0.0060.0640.225-0.121-1.131-0.175-2.5290.4060.3420.268
Income Tax Expense -2.124-0.327-10.86220.326-3.11-5.2-9.3860.4142.65348.42147.14837.54523.58966.51358.57114.526-0.5990.034-0.0380.0610.0070.013-0.217-0.318-0.1-0.434-0.349-0.415-0.110.1060.5030.4210.018-0.0591.2080.82100
Net Income -8.71-13.462-128.149-13.107-11.229-15.849-24.0761.34311.537153.979104.339122.52279.812200.691166.30746.6383.321-1.956-0.2961.4620.331-1.908-0.935-0.595-1.049-1.91-1.775-1.093-0.0250.2320.813-1.027-4.51-0.543-8.5450.3590.7460.425
Net Income Ratio -0.123-0.209-1.818-0.155-0.165-0.24-0.3560.0130.0920.4810.4150.5380.520.5580.5640.4590.192-0.252-0.0350.1410.039-0.355-0.165-0.106-0.194-0.41-0.415-0.243-0.0050.0440.139-0.205-1.136-0.158-2.9460.1240.3420.268
EPS -0.29-0.45-4.3-0.44-0.38-0.54-0.810.0450.385.093.484.132.746.966.552.110.15-0.091-0.0150.080.02-0.1-0.052-0.033-0.06-0.11-0.1-0.062-0.0010.010.05-0.06-0.26-0.043-0.670.0280.0580.033
EPS Diluted -0.29-0.45-4.3-0.44-0.38-0.54-0.810.0440.374.933.343.932.596.526.161.980.14-0.091-0.0150.080.02-0.1-0.052-0.033-0.059-0.11-0.1-0.062-0.0010.010.05-0.06-0.26-0.043-0.670.0280.0580.033
EBITDA -12.753-15.135-24.3546.633-13.486-22.856-34.5942.56826.931202.839151.771162.44698.898268.844225.90963.5232.64-1.914-0.4091.5090.295-1.823-1.016-0.846-1.001-2.194-1.988-1.481-0.150.6311.259-0.6111.218-0.416-7.1541.3510.870.495
EBITDA Ratio -0.18-0.235-0.3450.078-0.199-0.345-0.5110.0240.2150.6330.6030.7130.6440.7480.7660.6250.153-0.247-0.0490.1460.035-0.339-0.179-0.15-0.185-0.472-0.464-0.329-0.0320.1190.215-0.1220.307-0.121-2.4660.4650.3990.312